• About us
• Contact

Advertisement

Organisation › Details

Siemens (Group)

Siemens AG (Berlin and Munich) is a leading technology company focused on industry, infrastructure, mobility, and healthcare. The company’s purpose is to create technology to transform the everyday, for everyone. By combining the real and the digital worlds, Siemens empowers customers to accelerate their digital and sustainability transformations, making factories more efficient, cities more livable, and transportation more sustainable. Siemens also owns a majority stake in the publicly listed company Siemens Healthineers, a leading global medical technology provider pioneering breakthroughs in healthcare. For everyone. Everywhere. Sustainably. In fiscal 2024, which ended on September 30, 2024, the Siemens Group generated revenue of €75.9 billion and net income of €9.0 billion. As of September 30, 2024, the company employed around 312,000 people worldwide on the basis of continuing operations. *

 

	Industry	ELECTRONICS
	Industry 2	diagnostics (medical/biological)
	Region	München (Munich)
	Country	Germany
	Street	2 Wittelsbacher Platz
	City	80333 München
	Tel	+49-89-636-00
		Address record changed: 2024-01-05
Basic data	Employees	J: more than 100,0 (2024-09-30)
	Currency	EUR
	Annual sales	75,900,000,000 (revenue, consolidated (2023/24) 2024-09-30)
	Profit	9,000,000,000 (2024-09-30)
		* Document for »About Section«: Dotmatics Ltd.. (4/2/25). "Press Release: Dotmatics Signs Definitive Agreement to Be Acquired by Siemens Advancing a New Era of AI-Driven Innovation in Life Sciences". Boston, MA.
		Record changed: 2025-07-06

Advertisement

More documents for Siemens (Group)

• [1] Dotmatics Ltd.. (4/2/25). "Press Release: Dotmatics Signs Definitive Agreement to Be Acquired by Siemens Advancing a New Era of AI-Driven Innovation in Life Sciences". Boston, MA....
• [2] Dotmatics LLC. (12/10/24). "Press Release: Dotmatics and Databricks Partner to Advance Scientific Intelligence in Life Sciences". Boston, MA....
• [3] Dotmatics LLC. (9/25/24). "Press Release: Dotmatics Acquires Virscidian, Expanding Expertise in Analytical Chemistry and Chromatography and Mass Spectrometry". Boston, MA....
• [4] Dotmatics LLC. (7/30/24). "Press Release: Dotmatics Acquires EasyPanel to Expand Flow Cytometry Capabilities With Advanced Panel". Boston, MA....
• [5] Dotmatics LLC. (1/4/24). "Press Release: Dotmatics Acquires M-Star to Expand Presence in Bioprocessing and Chemicals & Materials Markets". Boston, MA....
• [6] Dotmatics LLC. (10/24/23). "Press Release: New Dotmatics Luma Scientific Data Platform Helps Scientists Analyze Massive Data Volumes to Enable AI and ML in Life Sciences"....
• [7] ASG Superconductors S.p.A.. (1/18/23). "Press Release: ASG Superconductors and Siemens Healthineers Join Forces to Deliver 10.5T Ultra High Field MRI Systems for Ground-breaking Brain Research". Genoa....
• [8] Dotmatics LLC. (4/26/22). "Press Release: Dotmatics, Previously Insightful Science, Set to Transform the Future of Scientific Software and Data Management". Boston, MA....
• [9] Insightful Science LLC. (1/13/22). "Press Release: Insightful Science Acquires Omiq to Add Cloud-Based Machine Learning to its Flow Cytometry Capabilities". San Diego, CA....
• [10] Insightful Science LLC. (12/21/21). "Press Release: Insightful Science Acquires Protein Metrics to Expand its R&D Solution to Include Proteomics". San Diego, CA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.